Skip to main content
Premium Trial:

Request an Annual Quote

Claudia Cherney Stewart, Dagmar Kasper, Elke Roschmann, Joanne Smith-Farrell, Richard Lerner, Robert Palazzo

Premium
Georgetown University last week said that Claudia Cherney Stewart has been appointed vice president of technology commercialization.
 
Stewart will report to Georgetown's senior vice president and will direct the university’s Office of Technology Licensing. She currently serves as director of the Office of Corporate Alliances at the University of Rochester, where she had previously served in a number of positions.
 
Prior to her arrival at Rochester she was vice president for research and operations at Redox Pharmaceutical. Stewart was recently appointed chairperson of the Committee on Industry and Foundation Relations for the National Institutes of Health’s Clinical and Translational Science Institute at the University of Rochester Medical Center. She holds a PhD in microbiology and a BS in biology from the University of Rochester, and received an NIH Fellowship in toxicology at the University of Cincinnati’s Institute of Environmental Health.
 

 
Epidauros has named Dagmar Kasper to be vice president of business development and marketing, and Elke Roschmann to the post of head of strategic development and licensing.
 
Kasper was formerly with Nordic Bioscience’s sales and marketing department and was a general manager at the company, and Roschmann formerly was in senior positions at Amersham Pharmacia and Integragen.
 

 
Joanne Smith-Farrell has resigned from Gene Logic as senior vice president of business development and licensing, according to a filing with the Securities and Exchange Commission. Farrell will leave her post on July 31.
 

 
Sequenom has appointed Richard Lerner to its board of directors. Lerner is president of the Scripps Research Institute, a professor of immunochemistry, and a member of the Skaggs Institute for Chemical Biology at Scripps. Lerner also serves on the boards at Kraft and Opko.
 

 
Robert Palazzo has recently taken over as president of the Federation of American Societies for Experimental Biology. Palazzo, who was also recently named provost of Rensselaer Polytechnic Institute, is founding director of RPI’s Center for Biotechnology and Interdisciplinary Studies.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.